ACT Earnings

ACT reported its earnings on 2026-02-03, showcasing a revenue of 312.71M against an estimate of 316.18M, resulting in a -1.1% surprise. The EPS was 1.23, surpassing the expected 1.09 by 12.84%. The stock experienced a 9.27% price change on the earnings day and a 5.11% change over the next five days, reflecting market reactions to the results.

Following ACT's earnings announcement on 2026-02-03, the stock price moved by 9.27% on the day of the release. Over the subsequent five days, it saw a 5.11% change. Historically, ACT's stock price tends to shift by an average of -0.71% in the 10 days leading up to earnings and 2.57% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ACT's annual revenue to reach 319.12M, while the EPS is projected at 1.15. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ACT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ACT's stock price typically moves by -0.71% in the 10 days before its earnings and 2.57% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.15 and revenue of 319.12M.

The earnings call reflects strong financial performance with increasing EPS and investment income. The company is optimistic about capital returns and the housing market, despite some concerns in specific geographic areas. The Q&A section shows confidence in managing risks and maintaining expense ratios. The company's strategic actions, including a ratings upgrade and successful reinsurance transactions, bolster its financial health. Considering these factors, alongside a market cap of $4.8 billion, the stock is likely to see a positive movement between 2% to 8%.